Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Boundless Bio, Inc.

NASDAQ: BOLD · Life Sciences · 5 alerts · CIK 1782303

Share price
$2.41Close, Nov 16
Market cap
$56.9M
Shares outstanding
23.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Boundless Bio, Inc. filings on SEC EDGAR ↗

7:06 AM ET 10-Q
Financial Results

Boundless Bio Q3 2026 Results: Net Loss of $5.36M, Loss Narrows

Boundless Bio, Inc. has entered into a definitive merger agreement with Serapha Bio, Inc., which will result in significant ownership dilution for existing stockholders and a potential reverse stock split. The company remains a clinical-stage biopharmaceutical firm with no revenue, a limited operating history, and expectations of continued significant operating losses as it develops its extrachromosomal DNA (ecDNA) directed therapeutic candidates.

Key figure
Net loss $5.36M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.